Acadia Pharmaceuticals Inc.
Industry
- Pharmaceuticals
- Vaccines
- Biotechnology
- Antisense, Oligonucleotides
Other Names/Subsidiaries
- Receptor Technologies
- CerSci Therapeutics
Latest on Acadia Pharmaceuticals Inc.
Aurobindo and MSN Labs are facing a wait of more than a decade to launch their proposed generic versions of Acadia Pharmaceuticals’ Nuplazid (pimavanserin tartrate) 34mg capsules after a US federal di
The 90-day pause on most of President Trump’s planned tariffs may have had a somewhat stabilizing effect on the stock market, but there is still significant volatility for the biopharma sector as th
The 90-day pause on most of President Trump’s planned tariffs may have had a somewhat stabilizing effect on the stock market, but there is still significant volatility for the biopharma sector as th
Soleno Therapeutics has gained US approval for Vykat XR, making it the first ever drug to treat hyperphagia, an intense, persistent hunger experienced by people with the rare genetic disorder Prader-W